1071517-39-9 | N-[3-[(4aR,5S,8R,8aS)-1-[(4-Fluorophenyl)methyl]-1,2,4a,5,6,7,8,8a-octahydro-4-hydroxy-2-oxo-5,8-methanoquinolin-3-yl]-1,1-dioxido-2H-1,2,4-benzothiadiazin-7-yl]methanesulfonamide

Packsize	Purity	Availability	Price	Discounted Price
1mg	95%	1 week	$264.00	$185.00
5mg	95%	1 week	$660.00	$462.00
10mg	95%	1 week	$941.00	$659.00

Description

• Catalog Number: AE17532
• Chemical Name: N-[3-[(4aR,5S,8R,8aS)-1-[(4-Fluorophenyl)methyl]-1,2,4a,5,6,7,8,8a-octahydro-4-hydroxy-2-oxo-5,8-methanoquinolin-3-yl]-1,1-dioxido-2H-1,2,4-benzothiadiazin-7-yl]methanesulfonamide
• CAS Number: 1071517-39-9
• Molecular Formula: C25H25FN4O6S2
• Molecular Weight: 560.6176
• MDL Number: MFCD00072099
• SMILES: Fc1ccc(cc1)CN1[C@H]2[C@@H]3CC[C@H]([C@H]2C(=C(C1=O)C1=Nc2ccc(cc2S(=O)(=O)N1)NS(=O)(=O)C)O)C3

Upstream Synthesis Route

Setrobuvir is a potent inhibitor that plays a crucial role in chemical synthesis by specifically targeting the viral nonstructural protein 5B (NS5B) polymerase. In the realm of drug development, Setrobuvir proves to be invaluable due to its ability to disrupt the replication of hepatitis C virus (HCV) by directly interfering with the NS5B enzyme, ultimately halting viral RNA synthesis. Through its mechanism of action, Setrobuvir demonstrates its significance as a key tool in the synthesis of antiviral agents aimed at combating HCV infections. Its precise targeting and inhibitory effects on NS5B make it a promising candidate for the creation of novel therapeutic agents with enhanced efficacy and specificity. By harnessing the power of Setrobuvir in chemical synthesis, researchers are able to advance the development of innovative antiviral treatments tailored to combat the complexities of HCV infection.